Patents
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
08/2009
08/27/2009CA2713184A1 2-aza-bicyclo[2.2.1]heptane derivatives
08/26/2009EP1646615B1 Pyrimidine derivatives as modulators of atp-binding cassette transporters
08/26/2009CN101516893A Novel 5, 7-disubstituted [1, 3 ] thiazolo [4, 5-d] pyrimidin-2 (3h)-one derevatives and their use in therapy
08/26/2009CN101516889A Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
08/26/2009CN101516879A Preparation and utility of substituted imidazopyridine compounds with hypnotic effects
08/25/2009US7579472 Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
08/25/2009US7579360 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
08/25/2009US7579343 3,4-dihydroxy,2,3,3a-4-tetrahydro-1-H-pyrrolo-[2,1c][1,4]benzothiazine
08/25/2009US7579342 Pteridine compounds for the treatment of psoriasis
08/25/2009US7578855 2-(3-Amino-pyrazolo[1,5-a]pyridin-2-ylamino)-ethyl]-trimethylammonium chloride;human hair dyes; cationic dyes; pyridine dyes; peroxide additive along with coupling agent;nontoxic; intensity; weaatherproofing; colorfastness; chemical resistance, permanent waves; uniform covering power; stability
08/25/2009CA2383466C Aromatic nitrogen-containing 6-membered cyclic compounds
08/20/2009US20090209755 Fused aminodihydrothiazine derivatives
08/19/2009EP2089397A1 5- [4- (azetidin-3-yl0xy) -phenyl]-2-phenyl-5h-thiaz0l0 [5,4-c]pyridin-4-0ne derivatives and their use as mch receptor antagonists
08/19/2009EP2089025A1 Thuggacin-type macrolide antibiotics and their use as antimycobacterial agents
08/19/2009CN101511832A Fused heterocyclic inhibitors of D-amino acid oxidase
08/19/2009CN100528882C Spirotetrathiocarbamates and spirooxothiocarbamates
08/18/2009US7576212 Thieno[2,3-B] pyridines as potassium channel inhibitors
08/18/2009US7576135 Cyclic diamine derivatives useful as agents for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism; inhibit activated blood coagulation factor X
08/18/2009US7576100 Muscarinic agonists
08/18/2009US7576091 Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinases
08/18/2009US7576078 Tetrahydroquinoline analogues as muscarinic agonists
08/18/2009CA2427831C Cyclization process step in the making of quinolones and naphthyridines
08/13/2009WO2009099982A1 2-aminopyridine kinase inhibitors
08/13/2009WO2009099929A1 Mesoionic pesticides
08/13/2009US20090203730 Bicyclic ppat inhibitors as antibacterial agents
08/13/2009CA2713347A1 Mesoionic pesticides
08/12/2009EP2088150A1 Fused pyrrolocarbazoles and methods for the preparation thereof
08/12/2009EP2086983A2 Fused ring compounds for inflammation and immune-related uses
08/12/2009EP2086537A1 Imidazo[2, 1-b]thiazoles and their use as pharmaceuticals
08/12/2009EP1463735B1 Imidazo¬2,1-b -1,3,4-thiadiazole sulfonamides
08/12/2009CN101506210A 2-phenoxy pyrimidinone analogues
08/12/2009CN101503414A Thiazolo[3,2-b]-1,2,4-triazine derivative and use thereof
08/11/2009US7572914 2-hydroxy-1H-indol derivatives enzyme inhibitors for preventing or treating inflammation, inflammatory bowel disease, psoriasis, dementia related diseases Alzheimer's Disease, Cognitive Impairment, arthritis, neurodegenerative diseases, amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease
08/11/2009US7572786 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
08/11/2009US7572784 Inhibit Aurora kinase; cancer; 4-[9-Chloro-7-(2-fluoro-phenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-ylamino]-N-(2-methylamino-ethyl)-benzamide; 9-Chloro-N-(4-{[3-(dimethylamino)azetidin-1-yl]carbonyl}phenyl)-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-amine
08/06/2009WO2009097490A1 1H-PYRAZOLO[3,4-D]PYRIMIDINE, PURINE, 7H-PURIN-8(9H)-ONE, 3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE, AND THIENO[3,2-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES
08/06/2009WO2009097014A2 Therapeutic kinase modulators
08/06/2009US20090198051 Chemical intermediates for sulfiding under mild conditions forming ring compounds for use as marine alkaloids; connecting reaction of 4 components, transforming c22-tert-butyltriphenylsilyl to acety group, cyclization, hydroxy group to methanesulonyl group, reduction of amide, dehydration,Heck reaction
08/05/2009EP2085401A1 Benzobisthiazole compound, benzobisthiazole polymer, organic film including the compound or polymer and transistor including the organic film
08/05/2009EP2084165A1 Positively charged water-soluble prodrugs of oxicams and related compounds with very high skin penetration rate
08/05/2009EP1496052B1 Novel aminobenzamide derivative
08/05/2009EP1399445B1 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists
08/05/2009CN101501032A Fused, tricyclic sulfonamide inhibitors of gamma secretase
08/05/2009CN101501017A Processes for the preparation of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino}sulfonyl}-2-thiophenecarboxamide
08/05/2009CN101501009A CGRP receptor antagonists
08/05/2009CN101497621A 1,5-dihydro-2H-pyrrol-2-one tricyclic derivatives having anti-infective activity
07/2009
07/30/2009WO2009093268A1 Process for the preparation of highly pure prulifloxacin
07/30/2009WO2009093009A1 Fused tricyclic thiophene derivatives as mek inhibitors
07/30/2009WO2009092764A1 Compounds comprising a cyclobutoxy group
07/30/2009WO2009073534A3 Bicyclic ppat inhibitors as antibacterial agents
07/30/2009US20090192313 Reacting 5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine with trichloroacetyl chloride; hydrolysis; industrial scale
07/30/2009US20090192308 1,5-dihydro-2h-pyrrol-2-one tricyclic derivatives having anti-infective activity
07/30/2009US20090192154 Sultam derivatives
07/30/2009US20090192145 Spiro-Imidazo Compounds
07/30/2009CA2710474A1 Compounds comprising a cyclobutoxy group
07/29/2009EP2083014A2 Inhibitors of interleukin-1ß converting enzyme
07/29/2009EP2083012A1 1,5-dihydro-2h-pyrrol-2-one tricyclic derivatives having pharmacological activity and processes for their preparation
07/29/2009CN100519565C N,N-bi-substituted-methylpyrazole (4,5,e) (2,1,3)-thiadiazine-2,2,4-triketone derivative, its production and application
07/29/2009CN100518736C Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
07/28/2009US7566707 For example, 2-[3-(Tert-butyloxycarbonylamino)-piperidin-1-yl]-3-(2-butyn-1-yl)-5-[(dibenzo[b,f][1,4]-oxazepin-11-yl)methyl]-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one; inhibiting effect on activity of the enzyme dipeptidylpeptidase-IV; use in treatment of diabetes mellitus, arthritis, obesity
07/23/2009WO2009091016A1 Condensed aminodihydrothiazine derivative
07/23/2009WO2009091014A1 Phenyl acetamide derivative
07/23/2009WO2009001214A3 Thieno[2,3-d]pyrimidin-4(3h)-one, isoxazolo[5,4-d]pyrimidin-4(5h)-one and isothiazolo[5,4-d]pyrimidin-4(5h)-one derivatives as calcium receptor antagonists
07/23/2009WO2008060597A8 Compounds useful as protein kinase inhibitors
07/23/2009US20090186888 Novel fused pyrrolocarbazoles
07/23/2009US20090186871 Tyrosine kinase inhibitors
07/23/2009US20090186830 Macrocycles and their uses
07/23/2009CA2712948A1 Phenylacetamide derivative
07/23/2009CA2711655A1 Condensed aminodihydrothiazine derivative
07/23/2009CA2710374A1 Fungicide hydroximoyl-tetrazole derivatives
07/22/2009EP2079749A2 Improved process for the preparation of (r)-(+)-4-(ethyiamino)-3,4-dihydro-2-(3- methoxypropyl)-2h-thieno[3,2-e]-l,2-thiazine-6-sulfonamide-l,l-dioxide
07/22/2009EP2079704A2 Therapeutic compounds
07/22/2009EP2079701A1 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators
07/22/2009EP2079690A2 3-aza-bicyclo[3.1.0]hexane derivatives
07/22/2009EP1644337B1 Melanocortin-4 receptor binding compounds and methods of use thereof
07/22/2009CN101490061A Thiadiazole compounds and methods of use thereof
07/22/2009CN101486679A 5HT2c receptor modulators
07/22/2009CN101486678A 5HT2C receptor modulators
07/22/2009CN101486677A 5HT2c receptor modulators
07/22/2009CN101485664A 5HT2c receptor modulators
07/21/2009US7563901 potent antimicrobial activity and a wide antimicrobial spectrum in a safe and cost effective reaction
07/21/2009US7563890 Synthons; nanomembranes
07/21/2009CA2367921C Bicyclic heterocycles, processes for their preparation and their use as herbicides and pharmaceutical agents
07/16/2009WO2009089547A1 Isothiazole-pyridine derivatives as modulators of hif (hypoxia inducible factor) activity
07/16/2009WO2009089057A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
07/16/2009WO2009089027A1 Phosphodiesterase inhibitors
07/16/2009WO2009087220A1 Use of thiazoloimidazoles, thiazolotetrazoles and thiazolotriazoles as mglur5 antagonists
07/16/2009WO2009087218A1 Thiazoltriazoles and thiazolimidazoles as antagonists of the mglur5 receptor
07/16/2009WO2009087127A1 Modulators for amyloid beta
07/16/2009US20090181965 Modulators for amyloid beta
07/16/2009US20090181955 Antibacterial Agents
07/16/2009US20090181942 Tricyclic compounds
07/16/2009US20090179638 Assay for identifying inhibitors of neuronal apoptotic pathways
07/16/2009CA2707441A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
07/16/2009CA2703824A1 Modulators for amyloid beta
07/15/2009EP2078004A1 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
07/15/2009EP2077836A2 Antidepressant, neuroprotectant, amyloid beta deposition inhibitor or age retardant containing heterocyclic compound
07/15/2009EP2077835A2 An alzheimer's disease progression inhibitor containing heterocyclic compound
07/15/2009EP1863774A4 Heterocyclical chromophore architectures with novel electronic acceptor systems
07/15/2009EP1458726B1 Mitotic kinesin inhibitors
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 152